Blackrock Capital Allocation Term Trust
Market Movers (8-K)
NYSE
8-K: BlackRock Capital Allocation Term Trust Reaches Standstill Agreement with Saba Capital Management
BlackRock Capital Allocation Term Trust and Saba Capital Management have entered into a standstill agreement, resolving a shareholder proposal and setting the stage for cooperation until 2027.
Insider Trading (Form 4)
NYSE
Richard M Rieder, Portfolio Manager of BlackRock Capital Allocation Term Trust, sold 35,734 shares of common stock on July 13, 2026 for $15.96 per share.
NYSE
BlackRock Capital Allocation Term Trust's Portfolio Manager, Sarah Croughan, reported transactions involving phantom shares and common stock.
NYSE
A BlackRock Capital Allocation Term Trust portfolio manager sold 5,554 common shares after converting phantom shares.
Worse than expected
NYSE
Randy William Berkowitz, a Portfolio Manager at BlackRock Capital Allocation Term Trust, reported the vesting and subsequent sale of common stock and phantom shares.
NYSE
Saba Capital Management, a 10% owner and director, decreased its holdings in BlackRock Capital Allocation Term Trust (BCAT) through recent sales.
NYSE
Saba Capital Management, a 10% owner and director, decreased its holdings in BlackRock Capital Allocation Term Trust (BCAT) through recent sales.
Proxy Statements (Def-14A)
NYSE
BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.
NYSE
BlackRock Closed-End Funds will hold a virtual joint annual meeting of shareholders on July 11, 2025, to vote on the election of board nominees.
NYSE
BlackRock Capital Allocation Term Trust urges shareholders to vote in favor of its board nominees and against Saba Capital's proposal to terminate BlackRock as investment manager at the upcoming annual meeting.
Better than expected
NYSE
Glass Lewis recommends shareholders vote for BlackRock's board nominees and against Saba Capital's proposals to terminate BlackRock as investment adviser for ten closed-end funds.
NYSE
BlackRock Capital Allocation Term Trust files a definitive proxy statement with the SEC.
NYSE
Institutional Shareholder Services (ISS) recommends shareholders vote against Saba Capital Management's proposals to terminate BlackRock as investment adviser for multiple closed-end funds and supports BlackRock's board nominees.
Better than expected
Schedule 13D - Activist Investments
NYSE
Saba Capital Management and affiliates have reduced their beneficial ownership in BlackRock Capital Allocation Term Trust to 4.87% through recent open market sales.
Worse than expected
NYSE
Saba Capital Management, L.P. and its affiliates have significantly reduced their beneficial ownership in BlackRock Capital Allocation Term Trust through a series of open market sales.
Worse than expected
NYSE
Saba Capital Management, L.P. and its affiliates have amended their Schedule 13D filing for BlackRock Capital Allocation Term Trust, disclosing a beneficial ownership of 6.32% and recent open market sales of common shares.
Worse than expected
NYSE
Saba Capital Management and its affiliates have filed an Amendment No. 19 to their Schedule 13D, disclosing a reduction in their beneficial ownership of BlackRock Capital Allocation Term Trust to 7.45% through open market sales.
NYSE
Activist investor Saba Capital Management, L.P. and its affiliates have significantly reduced their beneficial ownership in BlackRock Capital Allocation Term Trust, selling over 1 million shares in recent open market transactions.
Worse than expected
NYSE
SCHEDULE 13D/A: Saba Capital Reduces Stake in BlackRock Capital Allocation Term Trust, Discloses Recent Share Sales
Saba Capital Management, L.P. and its affiliates have filed an amended Schedule 13D, revealing a reduction in their beneficial ownership of BlackRock Capital Allocation Term Trust to 9.64% following a series of open market share sales.
Worse than expected